Table 2.
Patient characteristics and treatment outcomes (Intermediate-risk patients).
| RT-group | CCRT-group | P-value | |||
|---|---|---|---|---|---|
| Patient characteristics | Number of patients | 35 | 22 | ||
| Age (mean) | 49.8 | 49.6 | |||
| Clinical stage | IA2 | 0 | 0 | ||
| IB | 25 | 18 | |||
| IIA | 10 | 4 | |||
| IIB | 0 | 0 | |||
| Histology | Squamous cell | 27 | 13 | ||
| Adenocarcinoma | 5 | 0 | |||
| Adenosquamous | 3 | 9 | |||
| Others | 0 | 0 | |||
|
| |||||
| Treatment outcome | Duration of radiotherapy | Days | 37 | 37 | NS |
| Patients with recurrence (%) | 12 (34.3) | 1 (4.5) | .01 | ||
| PFS (months) | Mean | 29 | 36 | .0026 | |
| OS (months) | Mean | 32.5 | 36 | .0430 | |
PFS: progression-free survival, OS: overall survival, CCRT: concurrent chemoradiotherapy, RT: radiotherapy.